Fernwood Investment Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-2,925
Closed -$270K 188
2019
Q2
$270K Sell
2,925
-1,400
-32% -$133K 0.15% 126
2019
Q1
$408K Hold
4,325
0.22% 102
2018
Q4
$277K Sell
4,325
-2,000
-32% -$148K 0.18% 113
2018
Q3
$566K Buy
6,325
+600
+10% +$53K 0.3% 87
2018
Q2
$455K Buy
5,725
+500
+10% +$41.5K 0.25% 95
2018
Q1
$466K Buy
5,225
+1,250
+31% +$120K 0.26% 92
2017
Q4
$415K Buy
3,975
+100
+3% +$11.3K 0.22% 100
2017
Q3
$565K Buy
3,875
+325
+9% +$44.3K 0.35% 69
2017
Q2
$461K Hold
3,550
0.33% 84
2017
Q1
$442K Buy
3,550
+300
+9% +$35.9K 0.35% 72
2016
Q4
$376K Buy
3,250
+475
+17% +$52.9K 0.36% 82
2016
Q3
$290K Buy
+2,775
New +$300K 0.27% 89

Other funds holding CELG

Fernwood Investment Management's CELG Position: Q3 2019 in Review

Fernwood Investment Management sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 2,925 shares — an estimated $270K sold.

Fernwood Investment Management first reported a position in CELG in Q3 2016 and held it in 12 quarters. The position peaked at $566K in Q3 2018. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • Fernwood Investment Management reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
  • Fernwood Investment Management sold 2,925 Celgene Corp shares in Q3 2019, an estimated $270K.
  • Fernwood Investment Management first reported a position in Celgene Corp in Q3 2016 and held it in 12 quarters.
  • Fernwood Investment Management's Celgene Corp position peaked at $566K in Q3 2018.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on Fernwood Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.